Publication Information (EuropePMC) | |
Title | Genetic Risk Score Improves Risk Stratification for Anticoagulation-Related Intracerebral Hemorrhage. |
PubMed ID | 36756894(Europe PMC) |
doi | 10.1161/strokeaha.122.041764 |
Publication Date | Feb. 9, 2023 |
Journal | Stroke |
Author(s) | Mayerhofer E, Parodi L, Prapiadou S, Malik R, Rosand J, Georgakis MK, Anderson CD. |
Polygenic Score ID & Name | PGS Publication ID (PGP) | Reported Trait | Mapped Trait(s) (Ontology) | Number of Variants |
Ancestry distribution GWAS Dev Eval |
Scoring File (FTP Link) |
---|---|---|---|---|---|---|
PGS003457 (GRS_ICH) |
PGP000450 | Mayerhofer E et al. Stroke (2023) |
Intracerebral hemorrhage | intracerebral hemorrhage | 682,890 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003457/ScoringFiles/PGS003457.txt.gz |
PGS Performance Metric ID (PPM) |
Evaluated Score |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|---|
PPM017258 | PGS003457 (GRS_ICH) |
PSS010179| Multi-ancestry (including European)| 5,530 individuals |
PGP000450 | Mayerhofer E et al. Stroke (2023) |
Reported Trait: Incident intracerebral hemorrhage in anticoagulation therapy | HR: 1.24 [1.01, 1.53] | — | R²: 0.02 | age at baseline (controls) or ICH event (cases), sex, PC1 to 10, and genotyping array | — |
PPM017259 | PGS003457 (GRS_ICH) |
PSS010179| Multi-ancestry (including European)| 5,530 individuals |
PGP000450 | Mayerhofer E et al. Stroke (2023) |
Reported Trait: Incident intracerebral hemorrhage in anticoagulation therapy | HR: 1.33 [1.11, 1.59] | C-index: 0.57 [0.5, 0.64] | — | age at baseline (controls) or ICH event (cases), sex, PC1 to 10, and genotyping array, clinical risk score | — |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS010179 | The test cohort consisted of individuals without a history of ICH at baseline and anticoagulant use defined by self-report in the verbal interview at inclusion. Furthermore, individuals were included if they had a diagnosis of the International Classification of Diseases, Tenth Revision code Z92.1 (personal history of long-term (current) use of anticoagulants) or D68.3 (hemorrhagic disorder due to circulating anticoagulants) at baseline or a prescription of an anticoagulant medication between baseline and 6 months thereafter in the primary care data | Mean = 11.9 years | [ ,
69.0 % Male samples |
Mean = 62.0 years | European | — | UKB | — |
PSS010179 | The test cohort consisted of individuals without a history of ICH at baseline and anticoagulant use defined by self-report in the verbal interview at inclusion. Furthermore, individuals were included if they had a diagnosis of the International Classification of Diseases, Tenth Revision code Z92.1 (personal history of long-term (current) use of anticoagulants) or D68.3 (hemorrhagic disorder due to circulating anticoagulants) at baseline or a prescription of an anticoagulant medication between baseline and 6 months thereafter in the primary care data | Mean = 11.9 years | [ ,
69.0 % Male samples |
Mean = 62.0 years | Not reported | — | UKB | — |